DAIC

JANUARY 8, 2024

He was diagnosed with extensive coronary artery disease, resulting in ischemic cardiomyopathy and heart failure. Implanting the Penditure system during a minimally invasive mitral valve repair fixes two issues for the patient during one less traumatic procedure, leaving them with less pain and an easier recovery compared to surgery.”

Bicuspid/Mitral 124

Bicuspid/Mitral Atrial Fibrillation Anatomy Coronary Artery Disease 124

DAIC

FEBRUARY 15, 2024

According to a written statement, the GenePHIT trial aims to evaluate the safety and efficacy of a single intracoronary infusion of AB-1002 in adults with New York Heart Association (NYHA) Class III Heart Failure and non-ischemic cardiomyopathy who have been medically stable for at least 4 weeks.

Heart Failure 89

Heart Failure Cardiomyopathy Quality of Life Innovation 89

DAIC

MAY 6, 2024

We are committed to protecting the future commercial value of our innovative PH-HFpEF treatment,” said Chris Giordano , President & Chief Executive Officer of Tenax Therapeutics. Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. ,

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 105

DAIC

FEBRUARY 18, 2025

11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM). tim.hodson Tue, 02/18/2025 - 16:17 Feb.

Ultrasound 52

Ultrasound Echocardiogram Innovation Cardiomyopathy 52

Dr. S. Venkatesan MD

JULY 1, 2024

In simple terms it mimics a heart of Hypertrophic cardiomyopathy, which we know has brisk ejection. We can also understand the principles of the management of cardiomyopathy from a Giraffe’s heart. This forms the basis behind the ventricular reduction and reconstruction surgery for Ischemic dilated cardiomyopathy.(Batisda

Cardiomyopathy 52

Cardiomyopathy Aortic valve Aortic Blood Pressure 52

Cardiometabolic Health Congress

DECEMBER 5, 2024

As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. VANISH2 Trial : Catheter ablation as first-line therapy reduced VT episodes more effectively than antiarrhythmic drugs in ischemic cardiomyopathy patients.

CME 52

CME Innovation Obesity Cardiovascular Disease 52

Cardiology Update

JUNE 24, 2024

This comprehensive approach allows for precise differentiation between various cardiomyopathies, myocarditis, and myocardial infarction. This global collaboration of experts provides a platform for innovation, technical development, and dissemination of research findings.

Myocardial Infarction 52

Myocardial Infarction Anatomy Cardiovascular Imaging Research 52

DAIC

FEBRUARY 29, 2024

12:15 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Wellnest

JUNE 19, 2023

With the continued evolution of AI, it is now being introduced in cardiac healthcare, promising opportunities for innovation and advancements in cardiovascular medicine. The deep learning algorithm helps segment the left ventricle predicting cardiomyopathy and ejection fraction. For instance: 1.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

Still, Mirowski”s electrical kid survived the test of time and evolved with great technological innovations from companies like Medtronic, Guidant, Abbot etc. 2020) The un-disputable fact is ischemic DCM has a target to treat, though it is termed as cardiomyopathy. ICD explanation epidemic in the past was a true story.

Defibrillator 52

Defibrillator Heart Failure Sudden Cardiac Death Cardiomyopathy 52

Dr. Smith's ECG Blog

DECEMBER 27, 2018

Cardiologs founder, Yann Flereau, was named by MIT as the European Innovator of the Year. A Deep Neural Network learning algorithm outperforms a conventional algorithm for emergency department electrocardiogram interpretation. What an honor. This ECG is displayed on the Cardiologs platform. What do you think?

Chest Pain 40

Chest Pain Hypertension STEMI Heart Disease 40

Circulation

NOVEMBER 11, 2024

Methods:We analyzed data of ACE inhibitor naïve subjects with heart failure due to congenital heart disease (n=31) or dilated cardiomyopathy (n=3) from the prospective, open-label, multicenter phase II/III pharmacokinetic bridging studies using NONMEM®.

Heart Failure 40

Heart Failure Innovation ACE Inhibitor Congenital Heart Disease 40

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases. You can practically feel the energy and passion driving equal representation of women in medicine.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Frontiers in Cardiovascular Medicine

FEBRUARY 3, 2025

Atrial cardiomyopathy is a multifaceted heart disease characterized by structural and functional abnormalities of the atria and is closely associated with atrial fibrillation and its complications. Its etiology involves a number of factors, including genetic, infectious, immunologic, and metabolic factors.

Cardiomyopathy 52

Cardiomyopathy Atrial Fibrillation Transplant Diet 52

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

Diabetic cardiomyopathy (DCM) is one of the most prevalent and severe complications associated with diabetes mellitus (DM). Thus, it becomes imperative to uncover innovative approaches to facilitate the prompt identification and diagnosis of DCM. The onset of DCM is insidious, with the symptoms being obvious only in the late stage.

Cardiomyopathy 52

Cardiomyopathy Diabetes Research Biomarkers 52

Cardiometabolic Health Congress

JANUARY 2, 2025

November 2024 Approvals Acoramidis Approval Date: November 22, 2024 Indication: Approved for adults with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and severe cardiac condition. By prioritizing patient-centric innovation, these advancements emphasize the importance of addressing unmet medical needs.

Coronary Artery Disease 52

Coronary Artery Disease Stents Stent Innovation 52